{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T10:53:37Z","timestamp":1776682417596,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,15]]},"DOI":"10.7759\/cureus.82284","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T09:21:29Z","timestamp":1744708889000},"source":"Crossref","is-referenced-by-count":1,"title":["Updates in the Management of Hereditary Periodic Fever Syndromes in Children"],"prefix":"10.7759","author":[{"given":"Saroj K","family":"Tripathy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarthak","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvinder","family":"Wander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumi","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200211000-00020","article-title":"Recurrent fever in children","volume":"21","author":"John CC","year":"2002","unstructured":"John CC, Gilsdorf JR. Recurrent fever in children. Pediatr Infect Dis J. 2002, 21:1071-7. 10.1097\/00006454-200211000-00020","journal-title":"Pediatr Infect Dis J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease","volume":"27","author":"Masters SL","year":"2009","unstructured":"Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009, 27:621-68. 10.1146\/annurev.immunol.25.022106.141627","journal-title":"Annu Rev Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102421","article-title":"Systemic autoinflammatory diseases","volume":"109","author":"Krainer J","year":"2020","unstructured":"Krainer J, Siebenhandl S, Weinh\u00e4usel A. Systemic autoinflammatory diseases. J Autoimmun. 2020, 109:102421. 10.1016\/j.jaut.2020.102421","journal-title":"J Autoimmun"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/92.6.309","article-title":"Familial Mediterranean fever in children: the expanded clinical profile","volume":"92","author":"Majeed HA","year":"1999","unstructured":"Majeed HA, Rawashdeh M, el-Shanti H, Qubain H, Khuri-Bulos N, Shahin HM. Familial Mediterranean fever in children: the expanded clinical profile. QJM. 1999, 92:309-18. 10.1093\/qjmed\/92.6.309","journal-title":"QJM"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.1.79","article-title":"Acute phase response in familial Mediterranean fever","volume":"61","author":"Korkmaz C","year":"2002","unstructured":"Korkmaz C, Ozdogan H, Kasap\u00e7opur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis. 2002, 61:79-81. 10.1136\/ard.61.1.79","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910547","article-title":"Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients","volume":"11","author":"Magnotti F","year":"2019","unstructured":"Magnotti F, Lefeuvre L, Benezech S, et al.. Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients. EMBO Mol Med. 2019, 11:e10547. 10.15252\/emmm.201910547","journal-title":"EMBO Mol Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1457469","article-title":"Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis","volume":"29","author":"Varan \u00d6","year":"2019","unstructured":"Varan \u00d6, Kucuk H, Babaoglu H, et al.. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis. Mod Rheumatol. 2019, 29:363-6. 10.1080\/14397595.2018.1457469","journal-title":"Mod Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.668173","article-title":"Biotechnological agents for patients with tumor necrosis factor receptor associated periodic syndrome-therapeutic outcome and predictors of response: real-life data from the AIDA network","volume":"8","author":"Vitale A","year":"2021","unstructured":"Vitale A, Obici L, Cattalini M, et al.. Biotechnological agents for patients with tumor necrosis factor receptor associated periodic syndrome-therapeutic outcome and predictors of response: real-life data from the AIDA network. Front Med (Lausanne). 2021, 8:668173. 10.3389\/fmed.2021.668173","journal-title":"Front Med (Lausanne)"},{"key":"ref9","article-title":"TNF receptor-associated periodic fever syndrome","author":"Deuitch N","year":"2022","unstructured":"Deuitch N, Cudrici C, Ombrello A, et al.. TNF receptor-associated periodic fever syndrome. GeneReviews\u00ae. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington, Seattle, WA; 2022."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder","volume":"81","author":"Hull KM","year":"2002","unstructured":"Hull KM, Drewe E, Aksentijevich I, et al.. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore). 2002, 81:349-68. 10.1097\/00005792-200209000-00002","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-010-0160-9","article-title":"Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response","volume":"11","author":"Yu JR","year":"2011","unstructured":"Yu JR, Leslie KS. Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response. Curr Allergy Asthma Rep. 2011, 11:12-20. 10.1007\/s11882-010-0160-9","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0874","article-title":"Cryopyrinopathies: update on pathogenesis and treatment","volume":"4","author":"Neven B","year":"2008","unstructured":"Neven B, Prieur AM, Quartier dit Maire P. Cryopyrinopathies: update on pathogenesis and treatment. Nat Clin Pract Rheumatol. 2008, 4:481-9. 10.1038\/ncprheum0874","journal-title":"Nat Clin Pract Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.20033","article-title":"Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra","volume":"50","author":"Hawkins PN","year":"2004","unstructured":"Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 2004, 50:607-12. 10.1002\/art.20033","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010128","article-title":"Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today?","volume":"10","author":"Welzel T","year":"2021","unstructured":"Welzel T, Kuemmerle-Deschner JB. Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today?. J Clin Med. 2021, 10:128. 10.3390\/jcm10010128","journal-title":"J Clin Med"},{"key":"ref15","article-title":"Autoinflammatory syndromes behind the scenes of recurrent fevers in children","volume":"15","author":"Rigante D","year":"2009","unstructured":"Rigante D. Autoinflammatory syndromes behind the scenes of recurrent fevers in children. Med Sci Monit. 2009, 15:RA179-87.","journal-title":"Med Sci Monit"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01150","article-title":"Management of mevalonate kinase deficiency: a pediatric perspective","volume":"11","author":"Jeyaratnam J","year":"2020","unstructured":"Jeyaratnam J, Frenkel J. Management of mevalonate kinase deficiency: a pediatric perspective. Front Immunol. 2020, 11:1150. 10.3389\/fimmu.2020.01150","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna SW","year":"2014","unstructured":"Canna SW, de Jesus AA, Gouni S, et al.. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014, 46:1140-6. 10.1038\/ng.3089","journal-title":"Nat Genet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg N","year":"2014","unstructured":"Romberg N, Al Moussawi K, Nelson-Williams C, et al.. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet. 2014, 46:1135-9. 10.1038\/ng.3066","journal-title":"Nat Genet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3317-7","article-title":"A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome","volume":"36","author":"Rigante D","year":"2017","unstructured":"Rigante D, Vitale A, Natale MF, et al.. A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome. Clin Rheumatol. 2017, 36:463-8. 10.1007\/s10067-016-3317-7","journal-title":"Clin Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12722","article-title":"Canakinumab efficacy in refractory adult-onset PFAPA syndrome","volume":"20","author":"Lopalco G","year":"2017","unstructured":"Lopalco G, Rigante D, Vitale A, Caso F, Iannone F, Cantarini L. Canakinumab efficacy in refractory adult-onset PFAPA syndrome. Int J Rheum Dis. 2017, 20:1050-1. 10.1111\/1756-185X.12722","journal-title":"Int J Rheum Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0101-9","article-title":"PFAPA syndrome: a review on treatment and outcome","volume":"14","author":"Vanoni F","year":"2016","unstructured":"Vanoni F, Theodoropoulou K, Hofer M. PFAPA syndrome: a review on treatment and outcome. Pediatr Rheumatol Online J. 2016, 14:38. 10.1186\/s12969-016-0101-9","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00733-3","article-title":"Colchicine versus cimetidine: the better choice for periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome prophylaxis, and the role of MEFV gene mutations","volume":"20","author":"Raeeskarami SR","year":"2022","unstructured":"Raeeskarami SR, Sadeghi P, Vahedi M, Asna Ashari K, Mousavi T M, Ziaee V. Colchicine versus cimetidine: the better choice for periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome prophylaxis, and the role of MEFV gene mutations. Pediatr Rheumatol Online J. 2022, 20:72. 10.1186\/s12969-022-00733-3","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2014.03.026","article-title":"Vitamin D levels and effects of vitamin D replacement in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome","volume":"78","author":"Stagi S","year":"2014","unstructured":"Stagi S, Bertini F, Rigante D, Falcini F. Vitamin D levels and effects of vitamin D replacement in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. Int J Pediatr Otorhinolaryngol. 2014, 78:964-8. 10.1016\/j.ijporl.2014.03.026","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1302875","article-title":"The use of ketotifen as long-term anti-inflammatory prophylaxis in children with PFAPA syndrome","volume":"14","author":"Kapustova L","year":"2023","unstructured":"Kapustova L, Banovcin P, Bobcakova A, et al.. The use of ketotifen as long-term anti-inflammatory prophylaxis in children with PFAPA syndrome. Front Immunol. 2023, 14:1302875. 10.3389\/fimmu.2023.1302875","journal-title":"Front Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.02.038","article-title":"Effectiveness of adenotonsillectomy in PFAPA syndrome: a randomized study","volume":"155","author":"Garavello W","year":"2009","unstructured":"Garavello W, Romagnoli M, Gaini RM. Effectiveness of adenotonsillectomy in PFAPA syndrome: a randomized study. J Pediatr. 2009, 155:250-3. 10.1016\/j.jpeds.2009.02.038","journal-title":"J Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1103681108","article-title":"Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade","volume":"108","author":"Stojanov S","year":"2011","unstructured":"Stojanov S, Lapidus S, Chitkara P, et al.. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci U S A. 2011, 108:7148-53. 10.1073\/pnas.1103681108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei178","article-title":"Peculiarities of PAPA syndrome","volume":"45","author":"Tallon B","year":"2006","unstructured":"Tallon B, Corkill M. Peculiarities of PAPA syndrome. Rheumatology. 2006, 45:1140-3. 10.1093\/rheumatology\/kei178","journal-title":"Rheumatology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13603","article-title":"Autoinflammatory syndromes associated with hidradenitis suppurativa and\/or acne","volume":"56","author":"Vinkel C","year":"2017","unstructured":"Vinkel C, Thomsen SF. Autoinflammatory syndromes associated with hidradenitis suppurativa and\/or acne. Int J Dermatol. 2017, 56:811-8. 10.1111\/ijd.13603","journal-title":"Int J Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/21678707.2017.1375404","article-title":"Emerging treatments for pyoderma gangrenosum","volume":"5","author":"Wollina U","year":"2017","unstructured":"Wollina U. Emerging treatments for pyoderma gangrenosum. Expert Opin Orphan Drug. 2017, 5:827-32. 10.1080\/21678707.2017.1375404","journal-title":"Expert Opin Orphan Drug"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead323.041","article-title":"PAPA syndrome: response to methotrexate in four members of the same family","volume":"62","author":"Slimani S","year":"2023","unstructured":"Slimani S, Hadef D, Ghodbane NE. PAPA syndrome: response to methotrexate in four members of the same family. Rheumatology. 2023, 62:kead323.041. 10.1093\/rheumatology\/kead323.041","journal-title":"Rheumatology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich I","year":"2009","unstructured":"Aksentijevich I, Masters SL, Ferguson PJ, et al.. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009, 360:2426-37. 10.1056\/NEJMoa0807865","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.3490","article-title":"Response to interleukin (IL)-17 inhibition in an adolescent with severe manifestations of IL-36 receptor antagonist deficiency (DITRA)","volume":"153","author":"Cordoro KM","year":"2017","unstructured":"Cordoro KM, Ucmak D, Hitraya-Low M, Rosenblum MD, Liao W. Response to interleukin (IL)-17 inhibition in an adolescent with severe manifestations of IL-36 receptor antagonist deficiency (DITRA). JAMA Dermatol. 2017, 153:106-8. 10.1001\/jamadermatol.2016.3490","journal-title":"JAMA Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.15894","article-title":"Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement","volume":"6","author":"Lee PY","year":"2023","unstructured":"Lee PY, Davidson BA, Abraham RS, et al.. Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement. JAMA Netw Open. 2023, 6:e2315894. 10.1001\/jamanetworkopen.2023.15894","journal-title":"JAMA Netw Open"},{"key":"ref34","article-title":"Cyclic neutropenia","author":"Zergham AS","year":"2025","unstructured":"Zergham AS, Acharya U, Mukkamalla SKR. Cyclic neutropenia. StatPearls. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.02.682","article-title":"Severe pulmonary fibrosis as the first manifestation of interferonopathy (TMEM173 mutation)","volume":"150","author":"Picard C","year":"2016","unstructured":"Picard C, Thouvenin G, Kannengiesser C, et al.. Severe pulmonary fibrosis as the first manifestation of interferonopathy (TMEM173 mutation). Chest. 2016, 150:e65-71. 10.1016\/j.chest.2016.02.682","journal-title":"Chest"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-6198","article-title":"STING-associated vasculopathy with onset in infancy: a familial case series report and literature review","volume":"9","author":"Wang Y","year":"2021","unstructured":"Wang Y, Wang F, Zhang X. STING-associated vasculopathy with onset in infancy: a familial case series report and literature review. Ann Transl Med. 2021, 9:176. 10.21037\/atm-20-6198","journal-title":"Ann Transl Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12695","article-title":"Proteasome-associated autoinflammatory syndromes: advances in pathogeneses, clinical presentations, diagnosis, and management","volume":"54","author":"McDermott A","year":"2015","unstructured":"McDermott A, Jacks J, Kessler M, Emanuel PD, Gao L. Proteasome-associated autoinflammatory syndromes: advances in pathogeneses, clinical presentations, diagnosis, and management. Int J Dermatol. 2015, 54:121-9. 10.1111\/ijd.12695","journal-title":"Int J Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203666","article-title":"Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes","volume":"73","author":"Piram M","year":"2014","unstructured":"Piram M, Kon\u00e9-Paut I, Lachmann HJ, et al.. Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis. 2014, 73:2168-73. 10.1136\/annrheumdis-2013-203666","journal-title":"Ann Rheum Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/art.42139","article-title":"The 2021 EULAR\/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist","volume":"74","author":"Romano M","year":"2022","unstructured":"Romano M, Arici ZS, Piskin D, et al.. The 2021 EULAR\/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Arthritis Rheumatol. 2022, 74:1102-21. 10.1002\/art.42139","journal-title":"Arthritis Rheumatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1086\/421494","article-title":"Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor","volume":"39","author":"Mohan AK","year":"2004","unstructured":"Mohan AK, Cot\u00e9 TR, Block JA, Manadan AM, Siegel JN, Braun MM. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis. 2004, 39:295-9. 10.1086\/421494","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/355179-updates-in-the-management-of-hereditary-periodic-fever-syndromes-in-children","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T09:21:30Z","timestamp":1744708890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/355179-updates-in-the-management-of-hereditary-periodic-fever-syndromes-in-children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.82284","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}